|
Hi Birgitta,
thank you for the informations. What else can positively influence the platelets? Romiplostim and Promacta have been - and are - a hope for patients with this problem. I read, that you have a sort of bone marrow fibrosis together with your MDS, i understand you being so cautious with Romiplostin.
Why could it happen in the romiplostim-mds-study that patients converted to AML in such a short time, and with so many blasts? Perhaps a closer monitoring of the peripheral blood cells if not the bone marrow would have shown the danger of transformation earlier?
Nice regards,
Margarete
|